Healthcare & Life Sciences
Afynia
United States
seed
seed
Stage
1
Investors
About
Afynia develops a microRNA-based blood test to detect endometriosis, aiming to provide a non-invasive diagnostic option for the condition.
Explore Afynia's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.